Klaria Pharma Holding AB (KLAR) - Total Liabilities

Latest as of December 2025: Skr44.65 Million SEK ≈ $4.80 Million USD

Based on the latest financial reports, Klaria Pharma Holding AB (KLAR) has total liabilities worth Skr44.65 Million SEK (≈ $4.80 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Klaria Pharma Holding AB operating cash flow efficiency to assess how effectively this company generates cash.

Klaria Pharma Holding AB - Total Liabilities Trend (2014–2025)

This chart illustrates how Klaria Pharma Holding AB's total liabilities have evolved over time, based on quarterly financial data. Check Klaria Pharma Holding AB asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Klaria Pharma Holding AB Competitors by Total Liabilities

The table below lists competitors of Klaria Pharma Holding AB ranked by their total liabilities.

Company	Country	Total Liabilities
Peruvian Metals Corp V:PER	Canada	CA$877.79K
Hua Yang Bhd KLSE:5062	Malaysia	RM374.52 Million
Femasys Inc NASDAQ:FEMY	USA	$14.85 Million
Alla Public Company Limited BK:ALLA	Thailand	฿212.07 Million
Renrenle Commercial Group Co Ltd SHE:002336	China	CN¥2.06 Billion
Arctic Gold Publ AB ST:ARCT	Sweden	Skr8.58 Million
Guardian Exploration Inc V:GX	Canada	CA$2.09 Million
HiTi Digital Inc TW:3494	Taiwan	NT$1.23 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Klaria Pharma Holding AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Klaria Pharma Holding AB market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.05	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-11.50	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Klaria Pharma Holding AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Klaria Pharma Holding AB (2014–2025)

The table below shows the annual total liabilities of Klaria Pharma Holding AB from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr44.65 Million ≈ $4.80 Million	-17.26%
2024-12-31	Skr53.96 Million ≈ $5.81 Million	+69.62%
2023-12-31	Skr31.81 Million ≈ $3.42 Million	-28.01%
2022-12-31	Skr44.19 Million ≈ $4.76 Million	-9.62%
2021-12-31	Skr48.89 Million ≈ $5.26 Million	+114.33%
2020-12-31	Skr22.81 Million ≈ $2.45 Million	+16.29%
2019-12-31	Skr19.62 Million ≈ $2.11 Million	+69.77%
2018-12-31	Skr11.55 Million ≈ $1.24 Million	+391.91%
2017-12-31	Skr2.35 Million ≈ $252.79K	+17.80%
2016-12-31	Skr1.99 Million ≈ $214.59K	-13.04%
2015-12-31	Skr2.29 Million ≈ $246.76K	+356.14%
2014-12-31	Skr502.69K ≈ $54.10K	--

About Klaria Pharma Holding AB

ST:KLAR Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$23.19 Million

Skr215.48 Million SEK

Market Cap Rank

#24563 Global

#486 in Sweden

Share Price

Skr0.88

Change (1 day)

-1.13%

52-Week Range

Skr0.40 - Skr1.22

All Time High

Skr17.00